Accelerant Holdings· ARX
🇺🇸 US · MidBroad USNYSE
- Price
- $19.66
- Day
- -0.81%
- Mkt Cap
- $4.29B
- 52W Range
- $9.18 – $19.90
- Volume
- 6.77M
- Beta
- -0.40
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Are ARX, FULC, EFSI Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 15, 2026Insiders may stand to receive substantial financial benefits
Read full article
NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Julie & Holleman LLP, a law firm representing investors in securities and corporate governance matters, is investigating the proposed sale of Accelerant Holdings (NYSE: ARX) to private equity firm Thoma Bravo for $20.25 per share.
Read full article
Accelerant Holdings NYSE: ARX jumped into view for investors in mid-August after its shares surged 43% in a single day. This type of share price leap is often reserved for clinical-stage biotech firms announcing breakthrough results, for instance, not for an unglamorous firm connecting specialty insurance risk across a network of capital providers.
Read full article
Accelerant Holdings (NYSE: ARX - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $13.76 and traded as high as $19.78. Accelerant shares last traded at $19.77, with a volume of 1,488,977 shares changing hands. Analyst Upgrades and Downgrades A number
Read full article